ACIP releases the 2017 adult and childhood immunization schedules

United States of America
NITAGs
6 February 2017

The CDC and its Advisory Committee on Immunization Practices (ACIP), together with the AAFP and other medical professional organizations, have released the 2017 adult and childhood immunization schedules.

visitor_center.jpg

Changes this year include updated recommendations for a two-dose schedule of nine-valent HPV vaccine (HPV9; Gardasil 9) for patients ages 11-12, a two-dose schedule of meningitis B vaccine (MenB) for adolescents, a clarification regarding recommended adult candidates for hepatitis B (HepB) vaccine and revisions designed to make the adult schedule easier to navigate.

Release of the annual immunization schedules comes amid concerns that the Trump administration has proposed appointing a group to study the safety and effectiveness of vaccines.
In response, AAFP President John Meigs, M.D., of Centreville, Ala., said in a statement: "A new federal commission on immunizations is not necessary and would divert much-needed dollars from other, more pressing health care issues. To suggest the need for such an organization promotes unnecessary, ongoing and disproven skepticism about vaccines and public safety."

Meigs said plainly that vaccines are safe, effective and save lives, further explaining that allegations of a link between vaccines and autism have been thoroughly debunked.
"The science is clear, and family physicians stand ready to help everyone -- from the incoming administration to the general public -- understand how safe and important vaccines are," he stated.

Related News & Events

  • 25 -26
    October
    United States of America
    NITAGs

    MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)

    1600 Clifton Road, NE, Tom Harkin Global Communications Center, Kent "Oz" Nelson Auditorium
  • Costa Rica
    NITAGs

    Costa Rica introduces two new vaccines into the national immunization program

    16.10.2017

    October 2017 marks the introduction of the rotavirus and human papillomavirus (HPV) vaccines in Costa Rica’s immunization program. This decision results from the recommendations of the country National Immunization Technical Advisory Group (NITAG). Since 2001, Costa Rica’s NITAG, which is called Comisión Nacional de Vacunación y Epidemiología (National Commission on Vaccination and Epidemiology), is in charge of establishing and periodically updating the national immunization schedule as well as formulating overall policies and strategies for immunization. In order to issue the recommendations, the NITAG conducted cost-effectiveness studies that were then approved by its members.

    Read more
  • Canada
    NITAGs

    NACI mandate expands to support local decision-making on vaccine programs

    28.07.2017

    In June 2016 the Public Health Agency of Canada (PHAC) announced that the mandate of Canada’s NITAG, the National Advisory Committee on Immunization (NACI) will be expanded. In addition to the assessment of vaccine characteristics (safety, efficacy, effectiveness, and immunogenicity), NACI will also be assessing additional programmatic elements including economic evaluations, feasibility of implementation, acceptability, ethics and equity. 

    Read more